By Kelly Cloonan
Acrivon Therapeutics has appointed Dr. Mansoor Raza Mirza as chief medical officer, effective Wednesday.
Dr. Mirza joins the Watertown, Mass. clinical stage precision medicine company from Denmark's Copenhagen University National Medical Center, where he served as chief oncologist, Acrivon said Monday.
Mirza succeeds Dr. Jean-Marie Cuillerot, who entered the role in January of last year.
Mirza brings decades of clinical research and patient care experience, and specializes in gynecologic malignancies, or cancers affecting female reproductive organs, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 07, 2025 18:14 ET (22:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.